The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10820 malaria professionals are enjoying the free benefits of MalariaWorld today

anti‐malarial drug

Anti‐malarial drug effects on parasite dynamics in vivax malaria

March 24, 2021 - 14:41 -- Open Access
Author(s): 
Nicholas J. White
Reference: 
Malaria Journal 2021 20:161, 21 March 2021

Relapses of Plasmodium vivax malaria are prevented by 8-aminoquinolines. If hypnozoites survive, then the subsequent blood stage infections in early relapses (< 2 months) are suppressed by the slowly eliminated anti-malarial drugs used to treat the blood stage infection (chloroquine, artemisinin combination treatments), but they are not usually eliminated.

Progress and challenges in the use of fluorescence‐based flow cytometric assays for anti‐malarial drug susceptibility tests

January 27, 2021 - 11:48 -- Open Access
Author(s): 
Kasem Kulkeaw
Reference: 
Malaria Journal 2021 20:57, 21 January 2021

Drug-resistant Plasmodium is a frequent global threat in malaria eradication programmes, highlighting the need for new anti-malarial drugs and efficient detection of treatment failure. Plasmodium falciparum culture is essential in drug discovery and resistance surveillance. Microscopy of Giemsa-stained erythrocytes is common for determining anti-malarial effects on the intraerythrocytic development of cultured Plasmodium parasites. Giemsa-based microscopy use is conventional but laborious, and its accuracy depends largely on examiner skill.

Subscribe to RSS - anti‐malarial drug